Morning Overview on MSNOpinion
AbbVie’s new Parkinson’s pill is the first selective D1/D5 drug the FDA has approved
Tavapadon, sold under the brand name JUVMO, won FDA approval on September 28, 2026 for adults with Parkinson’s disease, and ...
Recommendations for RehabilitationWhen you hear the word "rehabilitation," what comes to mind?If you have spondyloarthritis, ...
Dr. Fox Remains a Shareholder and Member of the Board of Directors; Board Members Dr. David McFarland & Dr. Lorraine ...
Physical therapy isn't only for athletes. Anyone who needs help meeting movement goals and regaining independence can benefit ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
ABBV wins FDA approval for Juvmo, expanding its Parkinson's portfolio with a once-daily oral treatment and potential $5B-plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results